Bigul

Hopefully DCGI to give nod for Oxford's vaccine immediately: Biocon chief

India saw 37,975 new coronavirus infections in a day taking the country's Covid-19 caseload to 91.77 lakh
24-11-2020
Bigul

BIOCON LTD. - 532523 - Announcement under Regulation 30 (LODR)-Acquisition

Dear Sir/ Madam, Pursuant to Regulation 30 of the SEBI Listing Regulations, we wish to inform you that the Company has entered into an agreement on November 21, 2020 for acquisition of 26% equity stake on a fully diluted basis in Hinduja Renewables Two Private Limited ("HRTPL"), a special purpose vehicle formed for the purpose of power generation and developing a captive power plant as per Electricity laws.
23-11-2020
Bigul

BIOCON LTD. - 532523 - Disclosure Of Related Party Transactions For The Half Year Ended September 30, 2020

In compliance with Regulation 23(9) of SEBI Listing Regulations, please find enclosed disclosure of related party transactions on consolidated basis for the half year ended September 30, 2020, drawn in accordance with applicable accounting standard. The above information will also be available on the website of the company at www.biocon.com. Kindly take on record the above information and acknowledge.
21-11-2020

Top buy and sell ideas by Ashwani Gujral, Sudarshan Sukhani, Mitessh Thakkar for short term

Sudarshan Sukhani of s2analytics.com suggests selling Biocon with a stop loss of Rs 434, target at Rs 403 and Dabur India with a stop loss of Rs 520, target at Rs 474.
19-11-2020
Bigul

BIOCON LTD. - 532523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Meeting conducted with Institutional Investors/Research Analysts.
17-11-2020
Next Page
Close

Let's Open Free Demat Account